Hyperprolactinemia. Pathophysiology, clinical significance, therapy
Von Werder, K.; Fahlbusch, R.; Rjosk, H.K.
Der Internist 18(10): 520-528
1977
ISSN/ISBN: 0020-9554 PMID: 338540 Document Number: 118503
Document emailed within 1 workday
Related Documents
Schwarz, B.; Salak, N.; Hofstötter, H.; Pajik, W.; Knotzer, H.; Mayr, A.; Hasibeder, W. 1999: Intestinal ischemic reperfusion syndrome: pathophysiology, clinical significance, therapy Wiener Klinische Wochenschrift 111(14): 539-548Riemann, D.; Vorderholzer, U. 1998: Treatment of depression and sleep disorders. Significance of serotonin and L-tryptophan in pathophysiology and therapy Fortschritte der Medizin 116(32): 40-42
Radzivil, G.G.; Musarov, A.L. 1981: Clinical pathophysiology and intensive therapy of diffuse peritonitis Vestnik Khirurgii Imeni I. I. Grekova 126(2): 49-54
Hesselholt, M. 1985: Colic in horses. Pathophysiology, clinical examination and therapy Nordisk Veterinaermedicin 37(4): 201-216
Lüthy, R.; Berchthold, P.; Siegenthaler, G. 1971: Pathophysiology, clinical course, differential diagnosis and therapy of hepatic coma Schweizerische Rundschau für Medizin Praxis 60(41): 1351-1357
Rosegger, H. 1983: Meconium aspiration syndrome. 2. Pathophysiology, clinical aspects, therapy Wiener Klinische Wochenschrift 95(1): 9-14
Tofler, G.H.; Stone, P.H. 1986: Clinical patterns of angina pectoris. How pathophysiology determines therapy Postgraduate Medicine 80(6): 148-54 159-61 165-6
Lebreiro, A.; Martins, E.; Cruz, C.; Almeida, J.; Maciel, M.J.úl.; Cardoso, J.é C.; Lima, C.A. 2010: Marfan syndrome: clinical manifestations, pathophysiology and new outlook on drug therapy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 29(6): 1021-1036
Bokonjić, R. 1988: Present knowledge of pathogenesis, pathophysiology, clinical aspects and therapy of vascular headaches Neurologija 37(3-4): 83-104
Kaufmann, P.; Smolle, K.H.; Fleck, S.; Lueger, A. 1994: Ketoacidotic diabetic metabolic dysregulation: pathophysiology, clinical aspects, diagnosis and therapy Wiener Klinische Wochenschrift 106(5): 119-127
Corenblum, B.; Donovan, L. 1993: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia Fertility and Sterility 59(3): 671-673
Muneyyirci-Delale, O.; Goldstein, D.; Reyes, F.I. 1989: Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test New York State Journal of Medicine 89(4): 205-208
Von Werder, K.; Eversmann, T.; Fahlbusch, R.; Rjosk, H.K. 1978: Drug therapy of hyperprolactinemia and acromegaly Acta Medica Austriaca 5(3): 61-63
Von Werder, K. 1987: Growth hormone releasing hormone (GRH)--pathophysiology, clinical aspects, therapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 93: 386-394
Radowicki, S. 1983: Hyperprolactinemia in men - clinical aspects Polski Tygodnik Lekarski 38(18): 575-577
Rampello, L.; Nicoletti, G. 1990: The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia Medicina 10(3): 294-296
Kajdaniuk, D.; Marek, B.; Ostrowska, Z.; Kos-Kudła, B.; Buntner, B.; Wołkowska, K.; Kułakowska, E. 2000: Hyperprolactinemia--unappreciated clinical problem Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(53): 803-806
Campbell, S. 1990: Silent myocardial ischaemia: prevalence, pathophysiology and significance Journal of Human Hypertension 4(Suppl 2): 15-20
Navrátil, M. 1970: Significance of alveolar ventilation and dead space in respiratory pathophysiology Vnitrni Lekarstvi 16(3): 209-223
Dieckmann, K.P.; Loy, V.; Huland, H. 1989: Carcinoma in situ of the testis: clinical significance, diagnosis and therapy Der Urologe. Ausg. a 28(5): 271-280